drugset / Trial / NCT03918590

Post Intravitreal Injection Topical NSAID vs. Patching

NCT03918590

Phase 4 Unknown 60 enrolled The New York Eye & Ear Infirmary
RandomizedParallel-groupDouble-blindTreatment

Summary

A prospective randomized trial, to evaluate post-injection comfort measures comparing topical NSAID (nepafenac 0.3% suspension) and patching.

Timeline

Start
2018-12-03
Primary completion
2019-05-01
Completion
2019-06-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nepafenac Other / unclassified 0.3 % Topical